Vivesto
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
S Blvd 46 Fl 5, Solna, Stockholm, 169 73...Phone Number
+46 18505440Website
www.vivesto.comRevenue
<$5 MillionStock Symbol
OMAX.BEIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Vivesto
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea (paclitaxel micellar) is being made available to ovarian cancerpatients through a partnership with Elevar Therapeutics, Inc. Development programsinclude Cantrixil, in clinical development for late-stage ovarian cancer, and docetaxelmicellar, in development for advanced prostate cancer. Vivesto has proprietary drugdelivery technology designed to improve solubility, efficacy and safety.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivesto your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Vivesto has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Vivesto
Check out if Vivesto is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vivesto has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vivesto had a recent Job posting/layoffs
Earning: See what the market has to say on Vivesto recently announced quarterly report
Product Launch: Get notified when Vivesto launches new products
Vivesto, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vivesto is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vivesto is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vivesto.
Vivesto financials insights
Gather financial insights about Vivesto, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$9.5M
2016
Debt
$3.4M
Debt
$5.2M
2018
Debt
$13.1M
Vivesto Tech Stack
A closer look at the technologies used by Vivesto
Most Recent Scoops
Person-Based
Medical Research
Project
Vivesto has announced that its Paccal Vet program builds on a strong foundation of previous development work, documented data, and regulatory interactions. Through previous clinical trials, the product has been shown to be tolerable and safe to administer to dogs with an acceptable safety profile, having been given to more than 330 dogs.
Product Development, Clinical Operations, Manufacturing Operations
Project
Vivesto is conducting a pilot study in hemangiosarcoma dogs and a dose-finding study in cats, with top-line data anticipated in the second quarter of next year. To continue this development, Vivesto needs a partner.
Manufacturing Operations
Project
Vivesto is targeting the cat cancer therapy market, where there are over 75 million cats in US households alone and no FDA or USDA-approved cancer therapies for cats.
Business Intelligence, Analytics & Insights, Business Development
Project
Compliance, Regulations
Vivesto News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivesto
Sign Up For FreeTo access detailed company insights
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea (paclitaxel micellar) is being made available to ovarian cancerpatients through a partnership with Elevar Th... Read More
